Results 121 to 130 of about 12,517 (175)
Echoes and Shadows: Predicting Hepatorenal Syndrome Outcomes with Lung Ultrasound and X-rays. [PDF]
Kothekar AT, Shah KB.
europepmc +1 more source
Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: PRO. [PDF]
Belcher JM.
europepmc +1 more source
Hepatorenal Syndrome in the Setting of Intrahepatic Cholangiocarcinoma and Chronic Lymphedema: A Case Report. [PDF]
Lief S +4 more
europepmc +1 more source
Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: CON. [PDF]
Willows J, Hiremath S.
europepmc +1 more source
Point-of-care Ultrasonography in Patients with Hepatorenal Syndrome: A Single Center Observational Study. [PDF]
Amara V +12 more
europepmc +1 more source
Comparative Mortality Rates of Vasoconstrictor Agents in the Management of Hepatorenal Syndrome: A Systematic Review and Meta-Analysis. [PDF]
Olayinka OT +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Nature Reviews Disease Primers, 2018
Hepatorenal syndrome (HRS) is a form of kidney function impairment that characteristically occurs in cirrhosis. Recent changes in terminology have led to acute HRS beingĀ referred to as acute kidney injury (AKI)-HRS and chronic HRS as chronic kidney disease (CKD)-HRS.
Elsa Sola +2 more
exaly +7 more sources
Hepatorenal syndrome (HRS) is a form of kidney function impairment that characteristically occurs in cirrhosis. Recent changes in terminology have led to acute HRS beingĀ referred to as acute kidney injury (AKI)-HRS and chronic HRS as chronic kidney disease (CKD)-HRS.
Elsa Sola +2 more
exaly +7 more sources
Critical Care Clinics, 2021
Development of acute kidney injury in patients with chronic liver disease is common and portends a poor prognosis. Diagnosis remains challenging, as traditional markers, such as serum creatinine, are not reliable. Recent development of novel biomarkers may assist with this.
Saro, Khemichian +4 more
openaire +2 more sources
Development of acute kidney injury in patients with chronic liver disease is common and portends a poor prognosis. Diagnosis remains challenging, as traditional markers, such as serum creatinine, are not reliable. Recent development of novel biomarkers may assist with this.
Saro, Khemichian +4 more
openaire +2 more sources

